Arkolith/Insider Trading/KYTX/Form 4

Jones Ryan Alexander

Chief Financial OfficerKyverna Therapeutics, Inc. (KYTX) · full profile →Form 4 · filed May 29, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)11K$0.73$8K37K
May 28, 2024Option exercise(M)7K$0.73$5K44K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2024Option exercise(M)11K—$00
May 28, 2024Option exercise(M)7K—$02K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-065983) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML